Hyperbaric Oxygen Therapy is a new way used to treat a wide spectrum of conditions like acute or chronic wounds, infection, embolism, infertility and Alzheimer's disease.
A new research on breast cancer could be a possible game changer in the ongoing cure and impediment of the life-threatening affliction.
A newly developed 3D bioprinting technology by Wake Forest Baptist Medical Center scientists makes printing of human body parts available.
Knowing too much about the biology of a mental health condition can make doctors less empathetic, a new study reported.
Researchers have discovered how feedback between cells, as well as molecular factors, helps shape cortical development during mouse embryogenesis, according to a new study.
Researchers have identified a protein that is key to the self-replication of hematopoietic stem cells during human development, according to a new study.
In a couple of new researches, experts are reporting on how cancer cells succeed at circumventing the genetic program of growth inhibition.
Delivering stem cell factor directly into damaged heart muscle after a heart attack may help repair and regenerate injured tissue, suggests a new study.
Researchers have discovered a new way to repair damaged tissue by transforming human scar cells into blood vessel cells, according to a new study.
According to a new study, the number of genes linked to increasing autism risk has been expanded from nine to 33.
Within animals some cells are fated to die from the triggering of an elaborate cell death program, known as apoptosis. Now a study is offering a new explanation on the evolution of caspase-8, a key cell death initiator that was first identified in humans.
Cancer cells traveling to other sites have different energy needs from their 'stay-at-home' siblings which continue to proliferate at the original tumor site, suggests a new study.
Researchers have discovered a new class of compound that protects brain cells from the type of damage caused by blast-mediated traumatic brain injury (TBI), according to a new study.
Researchers at the University of California, San Diego School of Medicine, in partnership with the California Institute for Regenerative Medicine (CIRM) and Celgene Corporation, a New Jersey-based biopharmaceutical company, have launched a phase 1 human clinical trial to assess the safety and efficacy of a novel monoclonal antibody for patients suffering from chronic lymphocytic leukemia (CLL).
Researchers have demonstrated in a new study how an interplay between nutrition, metabolism and immunity is involved in the process of aging.